Interestingly, a previous immunohistochemical assay showed an increase in JAG1 expression with higher WHO grades of gliomas (levels from II to IV) (21), which indicates JAG1 protein expression maybe associated with progression of the disease. The gene discussed is JAG1; the disease is central nervous system cancer.